@article{86c006f4794f4d4ab79e88e7bef583d7,
title = "Prognostic value of Bcl-2 in two independent populations of estrogen receptor positive breast cancer patients treated with adjuvant endocrine therapy",
abstract = "Estrogen receptor (ER) status is not an optimal marker for response to adjuvant endocrine therapy since approximately 30% of patients with ER-positive tumors eventually relapse. Bcl-2 is regulated by ER and may thus be considered as an indicator of ER activity and a candidate supplementary marker to ER status.",
keywords = "Antineoplastic Agents, Hormonal, Breast Neoplasms, Carcinoma, Ductal, Breast, Chemotherapy, Adjuvant, Double-Blind Method, Female, Humans, Immunoenzyme Techniques, In Situ Hybridization, Fluorescence, Middle Aged, Neoplasm Grading, Prognosis, Proto-Oncogene Proteins c-bcl-2, Receptor, erbB-2, Receptors, Estrogen, Retrospective Studies, Survival Rate, Tamoxifen, Tissue Array Analysis",
author = "Larsen, {Mathilde S} and Karsten Bjerre and Anita Giobbie-Hurder and Anne-Vibeke L{\ae}nkholm and Henriksen, {Katrine L} and Bent Ejlertsen and Lykkesfeldt, {Anne Elisabeth} and Rasmussen, {Birgitte B}",
year = "2012",
doi = "10.3109/0284186X.2011.653009",
language = "English",
volume = "51",
pages = "781--9",
journal = "Acta Oncologica",
issn = "0284-186X",
publisher = "Medical Journals Sweden AB",
number = "6",
}